Favour Markson

Favour Markson

Auto-generated profile, based on publicly available information

Favour Markson

Department of Medicine, Lincoln Medical Center, Bronx, New York, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2024 in Korean Journal of Family Medicine
Verified
Journal Article
Open access
PDF file
MSManar Shalak
Manar Shalak
FMFavor Markson
Favor Markson
MNManoj Nepal
Manoj Nepal
Manifestations of gender-based violence although many, and sometimes more pronounced in areas of armed conflict, go unnoticed due to multiple factors. Gender-based violence targeted towards women, affect their overall health negatively, particularly the reproductive well-being. Major conflicts arising in the Middle East over the past 10–15 years, ranging from the Arab uprising to the Syrian civil war, have drawn attention world-wide. This study aims to shed light on the importance of recognizing violence against women, its effect on their reproductive health, and the policies that should be implemented to limit its adverse impact. Towards this end, we have highlighted the important role played by all healthcare professionals, epidemiologists, and surveyors working in peace and war areas to recognize such atrocities towards women.

1 August 2023 in Journal of Innovations in Cardiac Rhythm Management
Verified
Journal Article
Open access
FMFavour Markson
Favour Markson
EAEmmanuel Akuna
Emmanuel Akuna
IAIriagbonse Asemota
Iriagbonse Asemota
GAGabriel Areoye
Gabriel Areoye
ASAnoz Shahi
Anoz Shahi
KOKenneth Ong
Kenneth Ong
Protein–Energy Malnutrition Is Associated with Worse Outcomes in Patients with Atrial Fibrillation: A Nationwide Analysis

1 August 2025 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
FMFavour E. Markson
Favour E. Markson
TATemidayo A. Abe
Temidayo A. Abe
DFDavid S. Frankel
David S. Frankel
RSRobert D. Schaller
Robert D. Schaller
BACKGROUND: Frequent nonphysiological ventricular pacing and resultant pacing-induced cardiomyopathy are well characterized in transvenous pacemakers (TVP). The incidence of pacing-induced cardiomyopathy in leadless pacemakers (LP) is less understood, particularly compared with TVP. METHODS: We utilized the TriNetX Analytics Network database to identify 2594 propensity score-matched patients who underwent implantation of LP and TVP between January 1, 2016, and January 1, 2023. The primary outcome was the incidence of pacing-induced cardiomyopathy, defined as a new diagnosis of systolic heart failure or a left ventricular ejection fraction <50%, occurring from the index hospitalization through December 2024, after excluding other etiologies of heart failure. RESULTS: The median age of the study population was 73.8 years (±15). Baseline left ventricular ejection fraction was similar between groups (LP: 63±7 versus TVP: 64±8). During a median follow-up period of 2.4 years, 422 incident cases of PCM occurred. Incidence rates of pacing-induced cardiomyopathy were comparable (LP: 7.6% versus TVP: 8.6%; P =0.187), including in patients with pacing indications of complete heart block or atrioventricular nodal ablation (LP: 10.3% versus TVP: 10.4%; P =0.948). The mean drop in left ventricular ejection fraction was comparable between both groups; however, patients with LP were less likely to undergo cardiac resynchronization therapy upgrade compared with those with TVP (LP: 9.7% versus TVP: 17.5%; P =0.014). CONCLUSIONS: The incidence and characteristics of pacing-induced cardiomyopathy are similar between LP and TVP. However, patients with LP are less likely to undergo cardiac resynchronization therapy upgrade.

3 July 2024 in JACC: Advances
Verified
Journal Article
Open access
FMFavour E. Markson
Favour E. Markson
SASaint-Martin Allihien
Saint-Martin Allihien
AAAkanimo Antia
Akanimo Antia
OKOnoriode Kesiena
Onoriode Kesiena
KKKevin F. Kwaku
Kevin F. Kwaku
Ventricular arrhythmias (VAs) are a common cause of death in patients with acute myocardial infarction (AMI). Studies have shown sex differences in the incidence, presentation, and outcomes of AMI. However, less is known about sex differences in patients with AMI who develop VAs. The authors assessed sex differences in incidence and in-hospital outcomes of patients with AMI and VAs. Using the National Inpatient Sample 2016 to 2020, we conducted a retrospective analysis of patients admitted for AMI with a secondary diagnosis of VAs. Multivariable logistic regression was performed to estimate the sex-specific differences in the rates and in-hospital outcomes of VAs post-AMI. We identified 1,543,140 patients admitted with AMI. Of these, (11.3%) 174,565 patients had VAs after AMI. The odds of VAs after AMI were higher among men (12.6% vs 8.8% adjusted odds ratio [AOR]: 1.72; CI: 1.67-1.78; P < 0.001). Women had significantly higher odds of in-hospital mortality (AOR: 1.32; CI: 1.21-1.42; P < 0.001), cardiogenic shock (AOR: 1.08; CI: 1.01-1.15; P < 0.022), and cardiac arrest (AOR: 1.11; CI: 1.03-1.18; P < 0.002). Women were less likely to receive an implantable cardioverter-defibrillator (ICD) (AOR: 0.57; CI: 0.47-0.68; P < 0.001) or undergo catheter ablation (AOR: 0.51; CI: 0.27-0.98; P < 0.001) during the index admission. We found important sex differences in the incidence and outcomes of VAs among patients with AMI. Women had lower odds of VAs but worse hospital outcomes overall. In addition, women were less likely to receive ICD. Further studies to address these sex disparities are needed.

12 June 2023 in American Heart Journal Plus: Cardiology Research and Practice
Verified
Journal Article
Open access
FMF.E. Markson
F.E. Markson
EAE. Akuna
E. Akuna
CLC.Y. Lim
C.Y. Lim
LKL. Khemani
L. Khemani
AAA. Amanullah
A. Amanullah
The effect of the COVID-19 pandemic affected health care delivery, as it led to variable outcomes in different disease states including cardiovascular diseases. In this study, we evaluated the impact of coexisting COVID-19 on Acute Myocardial Infarction (AMI). We analyzed discharge records of AMI patients from the National Inpatient Sample (NIS) in the year 2020. Using propensity score matching, we assessed the impact of COVID-19 infection on the in-hospital outcomes of patients presenting with AMI. There were 1154 patients with concomitant COVID-19 infection and AMI who were matched with 109,990 patients with AMI and without COVID-19. We found that patients with COVID-19 who had AMI were less likely to have dyslipidemia (64.6 % vs. 70.4 %, p < 0.001), peripheral vascular disease (2.4 % vs. 3.8 % p = 0.0017), smoking history (23.5 % vs. 28.2 % p < 0.0001) and hypertension (37.1 % vs. 40.1 % p = 0.004). COVID-19 was associated with higher hospital mortality rates (Adjusted odds ratio aOR: 2.72, CI: 2.23–3.30, p < 0.001), cardiac arrest (aOR: 1.65, 95 % CI: 1.26–2.15, p < 0.001), cardiogenic shock (aOR:1.36,95 % CI: 1.10–1.68, p = 0.004) and respiratory failure (aOR:1.81, 95 % CI: 1.55–2.11 p < 0.001) compared to AMI patients without COVID-19. There was also a significant association between coexisting COVID-19 and longer duration of hospital stay (Adjusted mean differences:1.40, 95 % CI: 1.31–1.59 p < 0.0001) in AMI patients. COVID-19 infection is associated with worse in-hospital mortality and cardiorespiratory complications in patients with AMI.

24 August 2023 in American Heart Journal Plus: Cardiology Research and Practice
Verified
Journal Article
Open access
FMFavour Markson
Favour Markson
RSRimaskep Garba Shamaki
Rimaskep Garba Shamaki
AAAkanimo Antia
Akanimo Antia
AOAnita Osabutey
Anita Osabutey
MOModele O. Ogunniyi
Modele O. Ogunniyi
Pregnancy-related morbidity and mortality rates in the United States are rising despite advances in knowledge, technology, and healthcare delivery. Cardiovascular disease is the leading cause of adverse pregnancy outcomes, with acute myocardial infarction (AMI) being a potential contributor to the worse outcomes in pregnancy. We analyzed data from the national inpatient sample database to examine trends in the incidence and in-hospital outcomes of myocardial infarction in pregnancy from 2016 to 2020. Using ICD-10-CM codes, we identified all admissions from a pregnancy-related encounter with a diagnosis of type 1 AMI. Using the marginal effect of years, we assessed the trends in the incidence of AMI and utilized a multivariate logistic regression model to compare our secondary outcomes. Of the 19,524,846 patients with an obstetric-related admission, 3605 (0.02 %) had a diagnosis of type 1 AMI. Overall, we observed an approximately 2-fold increase in the trend of AMI from 1.4 to 2.5 per 10,000 obstetric admissions, with the highest incidence trend of 2.5 to 5.2 per 10,000 obstetric admissions seen in Black patients. Among patients diagnosed with AMI, we found significantly higher rates of in-hospital mortality (Adjusted Odds Ratio (AOR): 22.9, 12.2–42.8), cardiogenic shock (AOR:54.3, 33.9–86.6), preeclampsia (AOR: 2.2, 1.65–2.94) and spontaneous abortion (AOR:6.3, 3.71–10.6). Over the 5-year period, we found increasing trends in the incidence of AMI in pregnancy, especially among Black patients. Incident AMI was also associated with worse pregnancy outcomes.